Stock Events

Stock Events

Relmada Therapeutics (4E2.F) Q1 2026 Earnings

19MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.52

-0.39

-0.26

-0.13

Details

Expected EPS

-0.12838376125

Actual EPS

-0.2332287

Surprise EPS

-0.1

Surprise Percent

+81.67%

Description

Relmada Therapeutics (4E2.F) has reported earnings of -0.2332287 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.